Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about ALPMY
Recent news which mentions ALPMY
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
HILS
PFE
AXSM
From
Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
June 27, 2022
Tickers
ALPMF
ALPMY
Tags
Health Care
gene therapy
FDA
From
Benzinga
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
May 09, 2022
Tickers
ALPMF
ALPMY
TWST
Tags
Movers
Benzinga
News
From
Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
April 13, 2022
Tickers
ALPMF
ALPMY
SGEN
Tags
European Medicines Agency
Market News
Biotech
From
Benzinga
Astellas' Menopause Drug Suffers Setback After Failed Asian Trial
March 15, 2022
Tickers
ALPMF
ALPMY
Tags
General
Phase 3 Trial
ALPMF
From
Benzinga
Got $1,000? Here's a Dirt-Cheap Big Pharma Stock to Buy
March 15, 2022
Tickers
ALPMY
BMY
BNTX
JNJ
Tags
JNJ
ALPMY
PFE
From
Motley Fool
Astellas Touts Safety Data For Phase 3 Menopause Drug, Sets Up US Filing
March 07, 2022
Tickers
ALPMF
ALPMY
Tags
ALPMY
Benzinga
ALPMF
From
Benzinga
Astellas Pharma - Seagen's Enfortumab Shows 36% Pathologic Complete Response In Bladder Cancer Patients
February 15, 2022
Tickers
ALPMF
ALPMY
SGEN
Tags
Benzinga
News
Briefs
From
Benzinga
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
Tickers
ADAP
AGEN
ALPMY
GSK
Tags
XBI
ADAP
RHHBY
From
Motley Fool
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
Tickers
ALPMF
ALPMY
NVS
RHHBF
Tags
Trading Ideas
NVS
ALPMY
From
Benzinga
Astellas Pharma's Bladder Cancer Treatment Scores Approval In Japan
September 27, 2021
Tickers
ALPMF
ALPMY
Tags
Benzinga
Briefs
News
From
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Tickers
ABT
ACAD
ADGI
ALPMY
Tags
MCRB
AZRX
NRXP
From
Benzinga
Astellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Hold
September 14, 2021
Tickers
ALPMF
ALPMY
Tags
gene therapy
Health Care
Benzinga
From
Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
Tickers
ACIU
ADGI
ALKS
ALPMY
Tags
BCYC
PIRS
DVAX
From
Benzinga
See Why Astellas Stopped Dosing In Neuromuscular Disease Gene Therapy Trial
September 01, 2021
Tickers
ALM
ALPMF
ALPMY
Tags
News
Briefs
ALPMF
From
Benzinga
After FDA Rejection, EMA Approves FibroGen-Astellas' Roxadustat
August 20, 2021
Tickers
AKBA
ALPMF
ALPMY
AZN
Tags
ALPMY
Anemia
Trading Ideas
From
Benzinga
Here's What Recent News From the FDA Means for AstraZeneca
August 20, 2021
Tickers
ALPMY
AZN
FGEN
Tags
ALPMY
FGEN
Market News
From
Motley Fool
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Tickers
ABVC
ACAD
ACET
ADMA
Tags
HEPA
BLUE
AKUS
From
Benzinga
FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial
August 11, 2021
Tickers
ALPMF
ALPMY
AZN
FGEN
Tags
ALPMY
Anemia
Trading Ideas
From
Benzinga
Why Investors Should Like BioNTech's Latest Deal With Gilead
July 31, 2021
Tickers
ALPMY
BNTX
GILD
PFE
Tags
GILD
PFE
Market News
From
Motley Fool
The IPO Recap – Party Is Everything But Over
July 28, 2021
Tickers
ABSI
ALPMY
BASE
CNM
Tags
Markets
Tech
INST
From
Benzinga
Astellas - Seagen's PADCEV Wins Full FDA Approval And Expanded Label In Tough-To-Treat Urothelial Cancer
July 12, 2021
Tickers
ALPMF
ALPMY
SGEN
Tags
FDA
General
ALPMF
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.